Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Potent and selective AEA reuptake inhibitors as antispastics in MS

Jan. 23, 2006

Novel therapeutics for neurological disorders reported in recent patent literature

Jan. 20, 2006

FDA requests pediatric studies of zolpidem

Jan. 20, 2006

New German study evaluates AM-111 in acute sensorineural hearing loss

Jan. 20, 2006

IND submission for clinical trials of Myodur in Duchenne muscular dystrophy

Jan. 20, 2006

Ligand and Organon terminate Avinza copromotion

Jan. 20, 2006

PPARgamma activation suppresses BACE1 to reduce AD pathophysiology

Jan. 20, 2006

Series A financing at CoLucid Pharmaceuticals

Jan. 20, 2006

RF9: the first neuropeptide FF antagonist prevents opioid tolerance

Jan. 20, 2006

Novel analgesic agents disclosed in recent patents

Jan. 19, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...